New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compar
Oncology November 07,2023
New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

New treatment combination shows promise for metastatic colorectal cancer patients with rare genetic mutation

An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS G12C experienced superior progression-free survival rates compar
Oncology November 07,2023
New treatment options offer hope for patients with non-small cell lung cancer

New treatment options offer hope for patients with non-small cell lung cancer

More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumor cells, with less need for chemotherapy, following results of multipl
World medicine November 07,2023
New treatment options offer hope for patients with non-small cell lung cancer

New treatment options offer hope for patients with non-small cell lung cancer

More people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumor cells, with less need for chemotherapy, following results of multipl
World medicine November 07,2023
New "pseudo cell" formulation could revolutionize treatment of vitreoretinal diseases

New "pseudo cell" formulation could revolutionize treatment of vitreoretinal diseases

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and Beijing Chaoyang Hospital have developed a new "pseudo cell" formulation based on self-heal
World medicine November 07,2023
New "pseudo cell" formulation could revolutionize treatment of vitreoretinal diseases

New "pseudo cell" formulation could revolutionize treatment of vitreoretinal diseases

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences and Beijing Chaoyang Hospital have developed a new "pseudo cell" formulation based on self-heal
World medicine November 07,2023
New method uses extracellular vesicles to enhance immunotherapy responses in glioblastoma

New method uses extracellular vesicles to enhance immunotherapy responses in glioblastoma

A team of researchers at The University of Texas MD Anderson Cancer Center has developed a new method for using extracellular vesicles to enhance responses to immunotherapy in glioblastoma, potentiall
World medicine November 07,2023
New method uses extracellular vesicles to enhance immunotherapy responses in glioblastoma

New method uses extracellular vesicles to enhance immunotherapy responses in glioblastoma

A team of researchers at The University of Texas MD Anderson Cancer Center has developed a new method for using extracellular vesicles to enhance responses to immunotherapy in glioblastoma, potentiall
World medicine November 07,2023
New drug shows promise in killing cancer cells with genetic vulnerability

New drug shows promise in killing cancer cells with genetic vulnerability

Imagine the body's cells are well-behaved students in the classroom. The "teachers" are tumor suppressor genes, and they make sure cells follow the rules. But when tumor suppressor genes
World medicine November 07,2023
New drug shows promise in killing cancer cells with genetic vulnerability

New drug shows promise in killing cancer cells with genetic vulnerability

Imagine the body's cells are well-behaved students in the classroom. The "teachers" are tumor suppressor genes, and they make sure cells follow the rules. But when tumor suppressor genes
World medicine November 07,2023
Novel MRI metric predicts late genitourinary toxicity after prostate cancer treatment

Novel MRI metric predicts late genitourinary toxicity after prostate cancer treatment

A new Corewell Health study suggests that men who have longer prostatic urethras, the part of the urethra that travels through the prostate, may be at a higher risk of experiencing moderate, often chr
World medicine November 07,2023
Novel MRI metric predicts late genitourinary toxicity after prostate cancer treatment

Novel MRI metric predicts late genitourinary toxicity after prostate cancer treatment

A new Corewell Health study suggests that men who have longer prostatic urethras, the part of the urethra that travels through the prostate, may be at a higher risk of experiencing moderate, often chr
World medicine November 07,2023
Newly identified small molecule can suppress growth of breast and ovarian cancers in animal models

Newly identified small molecule can suppress growth of breast and ovarian cancers in animal models

Researchers at Baylor College of Medicine have identified a small molecule named 5D4 that can suppress the growth of breast and ovarian cancers in animal models. 5D4 works by binding to TopBP1 protein
World medicine November 07,2023
Newly identified small molecule can suppress growth of breast and ovarian cancers in animal models

Newly identified small molecule can suppress growth of breast and ovarian cancers in animal models

Researchers at Baylor College of Medicine have identified a small molecule named 5D4 that can suppress the growth of breast and ovarian cancers in animal models. 5D4 works by binding to TopBP1 protein
World medicine November 07,2023
The significance of education and health behavior in influencing health and wellbeing

The significance of education and health behavior in influencing health and wellbeing

In a recent study published inBMC Public Health, researchers investigated how health behaviors (HB) and socioeconomic position (SEP) were related to health and wellbeing.Study:The relative
World medicine November 07,2023
The significance of education and health behavior in influencing health and wellbeing

The significance of education and health behavior in influencing health and wellbeing

In a recent study published inBMC Public Health, researchers investigated how health behaviors (HB) and socioeconomic position (SEP) were related to health and wellbeing.Study:The relative
World medicine November 07,2023
Shedding light on the future of cognitive health in a graying world

Shedding light on the future of cognitive health in a graying world

In a recent study published inNpj Aging, researchers reviewed existing knowledge about age-related cognitive decline and changes in the brain based on studies from rodent models and humans, cove
World medicine November 07,2023
Shedding light on the future of cognitive health in a graying world

Shedding light on the future of cognitive health in a graying world

In a recent study published inNpj Aging, researchers reviewed existing knowledge about age-related cognitive decline and changes in the brain based on studies from rodent models and humans, cove
World medicine November 07,2023
Exploring the impact of solid oat polar lipid-enriched breakfasts on metabolic health

Exploring the impact of solid oat polar lipid-enriched breakfasts on metabolic health

In a recent study published inNutrients, researchers investigate whether oat polar lipid compounds incorporated in solid breakfasts improve glucose tolerance, gut hormonal responses, and triglyc
World medicine November 07,2023
Exploring the impact of solid oat polar lipid-enriched breakfasts on metabolic health

Exploring the impact of solid oat polar lipid-enriched breakfasts on metabolic health

In a recent study published inNutrients, researchers investigate whether oat polar lipid compounds incorporated in solid breakfasts improve glucose tolerance, gut hormonal responses, and triglyc
World medicine November 07,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com